UBS Increases Stake in LUYE PHARMA by 13.95 Million Shares at HK$2.85 Each
Stock News
Apr 13
On April 2, UBS purchased an additional 13.9545 million shares of LUYE PHARMA (02186) at HK$2.8547 per share, involving a total consideration of approximately HK$39.84 million. Following this transaction, UBS's total holdings in the company reached approximately 403 million shares, representing a 10.09% stake. Additional information: 218,500,000 of the reported long and short positions relate to the securities lending agreement executed in connection with the convertible bond issuance disclosed on June 28, 2023.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.